EIP
CVS icon

Epoch Investment Partners’s CVS Health CVS Stock Holding History

Epoch Investment Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146M Sell
2,039,191
-55,744
-3% -$4.29M 0.89% 23
2025
Q4 		$166M Sell
2,094,935
-158,895
-7% -$12.5M 0.94% 23
2025
Q3 		$170M Sell
2,253,830
-4,196
-0.2% -$288K 0.93% 22
2025
Q2 		$156M Buy
2,258,026
+472,240
+26% +$31M 0.81% 35
2025
Q1 		$121M Buy
1,785,786
+591,209
+49% +$35.4M 0.63% 61
2024
Q4 		$53.6M Sell
1,194,577
-924,679
-44% -$51.9M 0.26% 145
2024
Q3 		$133M Buy
2,119,256
+578,174
+38% +$33.7M 0.6% 55
2024
Q2 		$91M Sell
1,541,082
-609,423
-28% -$38.1M 0.42% 81
2024
Q1 		$172M Buy
2,150,505
+174,015
+9% +$13.3M 0.76% 36
2023
Q4 		$156M Sell
1,976,490
-82,036
-4% -$5.84M 0.71% 31
2023
Q3 		$144M Sell
2,058,526
-234,995
-10% -$16.7M 0.92% 22
2023
Q2 		$159M Buy
2,293,521
+292,069
+15% +$20.8M 0.92% 21
2023
Q1 		$149M Buy
2,001,452
+248,208
+14% +$20.8M 0.89% 23
2022
Q4 		$163M Buy
1,753,244
+1,075,772
+159% +$104M 0.97% 21
2022
Q3 		$64.6M Sell
677,472
-16,993
-2% -$1.68M 0.42% 79
2022
Q2 		$64.3M Buy
694,465
+94,163
+16% +$9.19M 0.38% 91
2022
Q1 		$60.8M Sell
600,302
-32,667
-5% -$3.43M 0.3% 112
2021
Q4 		$65.3M Buy
632,969
+35,266
+6% +$3.26M 0.33% 105
2021
Q3 		$50.7M Sell
597,703
-26,256
-4% -$2.2M 0.28% 113
2021
Q2 		$52.1M Buy
623,959
+11,026
+2% +$903K 0.28% 111
2021
Q1 		$46.1M Buy
612,933
+163,256
+36% +$11.9M 0.22% 134
2020
Q4 		$30.7M Buy
449,677
+168,234
+60% +$10.9M 0.14% 154
2020
Q3 		$16.4M Sell
281,443
-21,047
-7% -$1.31M 0.08% 181
2020
Q2 		$19.7M Buy
302,490
+13,692
+5% +$862K 0.1% 167
2020
Q1 		$17.1M Buy
288,798
+62,645
+28% +$4.18M 0.1% 164
2019
Q4 		$16.8M Buy
226,153
+3,202
+1% +$225K 0.07% 175
2019
Q3 		$14.1M Sell
222,951
-2,131
-0.9% -$126K 0.06% 175
2019
Q2 		$12.3M Buy
225,082
+60,129
+36% +$3.24M 0.06% 188
2019
Q1 		$8.9M Sell
164,953
-3,707,747
-96% -$229M 0.04% 216
2018
Q4 		$254M Buy
3,872,700
+3,679,925
+1,909% +$275M 1.18% 16
2018
Q3 		$15.2M Buy
192,775
+4,563
+2% +$326K 0.06% 203
2018
Q2 		$12.1K Sell
188,212
-15,019
-7% -$990K 0.04% 219
2018
Q1 		$12.6M Sell
203,231
-6,846
-3% -$491K 0.04% 212
2017
Q4 		$15.2M Sell
210,077
-8,878
-4% -$645K 0.05% 207
2017
Q3 		$17.8M Sell
218,955
-5,926
-3% -$469K 0.06% 198
2017
Q2 		$18.1M Sell
224,881
-6,284
-3% -$496K 0.06% 196
2017
Q1 		$18.1M Buy
231,165
+209,454
+965% +$16.7M 0.06% 193
2016
Q4 		$1.71M Sell
21,711
-1,717,189
-99% -$139M 0.01% 257
2016
Q3 		$155M Sell
1,738,900
-924,326
-35% -$87.2M 0.58% 65
2016
Q2 		$255M Sell
2,663,226
-771,233
-22% -$76.9M 0.96% 36
2016
Q1 		$356M Sell
3,434,459
-2,082,930
-38% -$203M 1.35% 20
2015
Q4 		$539M Buy
5,517,389
+583,134
+12% +$57.1M 2.14% 6
2015
Q3 		$476M Sell
4,934,255
-585,711
-11% -$61.6M 1.85% 6
2015
Q2 		$579M Sell
5,519,966
-132,666
-2% -$13.6M 2.14% 5
2015
Q1 		$583M Sell
5,652,632
-2,280,012
-29% -$231M 2.19% 5
2014
Q4 		$764M Sell
7,932,644
-331,639
-4% -$29.2M 2.76% 3
2014
Q3 		$658M Buy
8,264,283
+129,397
+2% +$10.2M 2.56% 4
2014
Q2 		$613M Buy
8,134,886
+288,163
+4% +$21.8M 2.39% 3
2014
Q1 		$587M Buy
7,846,723
+598,775
+8% +$42.3M 2.36% 3
2013
Q4 		$519M Buy
7,247,948
+546,721
+8% +$35.1M 2.19% 4
2013
Q3 		$380M Buy
6,701,227
+501,392
+8% +$29.9M 1.7% 7
2013
Q2 		$355M Buy
+6,199,835
New +$359M 1.77% 9

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Epoch Investment Partners's CVS Position: Q1 2026 in Review

Epoch Investment Partners reduced its CVS Health (CVS) stake by 2.7% in Q1 2026, selling an estimated $4.29M and leaving 2,039,191 shares worth $146M. The position accounts for 0.89% of the portfolio, ranked #23.

Epoch Investment Partners first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $764M in Q4 2014. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Epoch Investment Partners held 2,039,191 shares of CVS Health worth $146M as of Q1 2026.
  • Epoch Investment Partners sold 55,744 CVS Health shares in Q1 2026, an estimated $4.29M.
  • CVS Health made up 0.89% of Epoch Investment Partners's portfolio in Q1 2026, its #23 holding.
  • Epoch Investment Partners first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Epoch Investment Partners's CVS Health position peaked at $764M in Q4 2014.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.